Your browser doesn't support javascript.
loading
Efficacy of treatment based on TKIs in combination with PD-1 inhibitors for unresectable recurrent hepatocellular carcinoma.
Zhang, Ze; Jiao, Tianyu; Li, Junfeng; Hu, Bingyang; Zhang, Wenwen; Wang, Zhijun; Wan, Tao; Wang, Yafei; Lu, Shichun.
Afiliação
  • Zhang Z; Medical School of Chinese People's Liberation Army (PLA), Beijing, China.
  • Jiao T; Faculty of Hepato-Pancreato-Biliary Surgery, Chinese PLA General Hospital, Beijing, China.
  • Li J; Institute of Hepatobiliary Surgery of Chinese PLA, Beijing, China.
  • Hu B; Key Laboratory of Digital Hepatobiliary Surgery, PLA, Beijing, China.
  • Zhang W; Medical School of Chinese People's Liberation Army (PLA), Beijing, China.
  • Wang Z; Faculty of Hepato-Pancreato-Biliary Surgery, Chinese PLA General Hospital, Beijing, China.
  • Wan T; Institute of Hepatobiliary Surgery of Chinese PLA, Beijing, China.
  • Wang Y; Key Laboratory of Digital Hepatobiliary Surgery, PLA, Beijing, China.
  • Lu S; Medical School of Chinese People's Liberation Army (PLA), Beijing, China.
World J Surg Oncol ; 21(1): 53, 2023 Feb 18.
Article em En | MEDLINE | ID: mdl-36803872
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quimioembolização Terapêutica / Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quimioembolização Terapêutica / Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article